PCSK9 Inhibition and Oxidized Phospholipids

被引：10
|
作者：
Bhatia, Harpreet S. [1 ]
Yeang, Calvin [1 ]
Baruch, Amos [1 ]
Yang, Xiaohong [1 ]
Stroes, Erik S. G. [1 ]
Tsimikas, Sotirios [1 ]
机构：
[1] Univ Calif San Diego, Sulpizio Cardiovasc Ctr, Vasc Med Program, 9500 Gilman Dr,BSB 1080, La Jolla, CA 92093 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 78卷 / 12期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.jacc.2021.07.031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1288 / 1289
页数：2
相关论文
共 50 条
  • [31] PCSK9 inhibition and type 2 diabetes
    Lotta, Luca A.
    Griffin, Simon J.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (12): : 926 - 927
  • [32] The consequences of PCSK9 inhibition in selected tissues
    Maliglowka, Mateusz
    Buldak, Lukasz
    Okopien, Boguslaw
    Boldys, Aleksandra
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2021, 75 : 385 - 397
  • [33] PCSK9 Inhibition to Reduce Cardiovascular Events
    Dullaart, Robin P. F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1790 - 1791
  • [34] An oral antisense oligonucleotide for PCSK9 inhibition
    Gennemark, Peter
    Walter, Katrin
    Clemmensen, Niclas
    Rekic, Dinko
    Nilsson, Catarina A. M.
    Knochel, Jane
    Holtta, Mikko
    Wernevik, Linda
    Rosengren, Birgitta
    Kakol-Palm, Dorota
    Wang, Yanfeng
    Yu, Rosie Z.
    Geary, Richard S.
    Riney, Stan J.
    Monia, Brett P.
    Isaksson, Rikard
    Jansson-Lofmark, Rasmus
    Rocha, Cristina S. J.
    Linden, Daniel
    Hurt-Camejo, Eva
    Crooke, Rosanne
    Tillman, Lloyd
    Ryden-Bergsten, Tina
    Carlsson, Bjorn
    Andersson, Ulf
    Elebring, Marie
    Tivesten, Anna
    Davies, Nigel
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (593)
  • [35] PCSK9 inhibition and the global diabetes epidemic
    Mascitelli, Luca
    Goldstein, Mark R.
    DIABETOLOGIA, 2017, 60 (04) : 751 - 752
  • [36] New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide
    Landmesser, Ulf
    Makhmudova, Umidakhon
    CIRCULATION, 2023, 148 (02) : 159 - 161
  • [37] The biology of PCSK9 inhibition: some unanswered questions
    Lambert, Gilles
    Diotel, Nicolas
    Tavori, Hagai
    EUROPEAN HEART JOURNAL, 2016, 37 (17) : 1345 - 1347
  • [38] Lipids and PCSK9 inhibition in chronic kidney disease
    Schunk, S. J.
    Fliser, D.
    Speer, T.
    NEPHROLOGE, 2020, 15 (05): : 285 - 292
  • [39] PCSK9 INHIBITION AND AORTIC STENOSIS IN THE FOURIER TRIAL
    Bergmark, Brian
    O'Donoghue, Michelle
    Murphy, Sabina
    Kuder, Julia
    Ezhov, Marat V.
    Ceska, Richard
    Gouni-Berthold, Ioanna
    Jensen, Henrik Kjaerulf
    Tokgozoglu, Sadberk Lale
    Mach, Francois
    Huber, Kurt
    Gaciong, Zbigniew
    Lewis, Basil S.
    Schiele, Francois
    Jukema, Johan Wouter
    Pedersen, Terje
    Giugliano, Robert
    Sabatine, Marc Steven
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2112 - 2112
  • [40] PCSK9 inhibition in high-risk patients
    Zijlstra, Laurien E.
    Mooijaart, Simon P.
    Jukema, J. Wouter
    AGING-US, 2019, 11 (23): : 10791 - 10792
12345